Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Mechanisms of action of medicines for schizophrenia and bipolar illness: status and limitations.

Biological psychiatry - 1 Jun 2006

Scolnick Edward M

Abstract excerpt

This paper is not a comprehensive review of the literature. Rather, it is a viewpoint based upon advances in other fields of medicine and genetics that may provide a model for guiding research in psychiatry. The paper discusses the major limitations of the medicines currently used to treat schizophrenia and bipolar illness. The limitations in our understanding of the molecular causes of these two illnesses and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antipsychotic Agents
Share to Bipolar Disorder
Share to Genetic Predisposition to Disease

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Schizophrenia

Share to Treatment Outcome

Source

Identifiers

PMID: 16616720
DOI: 10.1016/j.biopsych.2006.02.022

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Mechanisms of action of medicines for schizophrenia and bipolar illness: status and limitations.PMID 16616720Read ↗

The Path to New Therapies for Schizophrenia and Bipolar Illness.Semantic proximity Read ↗

Pharmacologic and genetic evidence converge on mechanisms of psychotic illnessSemantic proximity Read ↗

Schizophrenia: from mechanism to therapy.Semantic proximity Read ↗

[Approach for identifying novel drug targets of schizophrenia].Semantic proximity Read ↗

Drawbacks of Olanzapine Therapy: An Emphasis on Its Metabolic Effects and DiscontinuationSemantic proximity Read ↗

Candidates for Drug Repurposing to Address the Cognitive Symptoms in SchizophreniaSemantic proximity Read ↗

Focusing on drug versus disease mechanisms and on clinical subgrouping to advance personalised medicine in psychiatry.Semantic proximity Read ↗

Use of biomarkers in the discovery of novel anti-schizophrenia drugs.Semantic proximity Read ↗

The role of antipsychotics and other drugs on the development and progression of Neuroleptic Malignant SyndromeSemantic proximity Read ↗

Basic data for bipolar disorders: genetics, neurobiology and pharmacology.Semantic proximity Read ↗

Potential microbial origins of schizophrenia and their treatments.Semantic proximity Read ↗

The search for novel antipsychotics: pharmacological and molecular targets.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.